Global Gastrointestinal Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Gastrointestinal Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn"s disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

According to our (Global Info Research) latest study, the global Gastrointestinal market size was valued at US$ 37030 million in 2023 and is forecast to a readjusted size of USD 46130 million by 2030 with a CAGR of 3.2% during review period.

Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.

Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.

In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.

This report is a detailed and comprehensive analysis for global Gastrointestinal market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Gastrointestinal market size and forecasts, in consumption value ($ Million), 2019-2030

Global Gastrointestinal market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Gastrointestinal market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Gastrointestinal market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Gastrointestinal

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Gastrointestinal market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZenec, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria（Tillotts）, Perrigo, Boehringer Ingelheim, Purdue Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Gastrointestinal market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Gastrointestinal market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug

Market segment by Application
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others

Market segment by players, this report covers
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Gastrointestinal product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Gastrointestinal, with revenue, gross margin, and global market share of Gastrointestinal from 2019 to 2024.

Chapter 3, the Gastrointestinal competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gastrointestinal market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal.

Chapter 13, to describe Gastrointestinal research findings and conclusion.